Merck Q4 Profit Beats Expectations, but Revenue Falls Short (MRK)

By Staff,

Shutterstock photo

Drug maker Merck & Co., Inc. ( MRK ) Thursday said it swung to a fourth quarter profit, reversing a year-ago loss caused by massive one-time expenses.

The Whitehouse Station, NJ-based company reported fourth quarter net income of $1.51 billion, or 49 cents per share, compared with a net loss of $531 million, or -17 cents per share, in the year-ago period. Excluding one-time items, adjusted profit was 97 cents per shares.

Revenue rose 2% from last year to $12.29 billion.

On average, Wall Street analysts expected a smaller profit of 97 cents per share, albeit on higher revenue of $12.53 billion.

Merck shares rose 47 cents, or +1.2%, in premarket trading Thursday.

The Bottom Line
Shares of Merck ( MRK ) have a 4.35% dividend yield, based on last night's closing stock price of $38.63. The stock has technical support in the $35-$36 price area. If the shares can firm up, we see overhead resistance around the $40-$41 price levels.

Merck & Co., Inc. ( MRK ) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Created by

This article appears in: Investing Stocks
Referenced Stocks: MRK

More from

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by